E3 PreliminaryPreliminaryPEM requiredPeer-reviewedMachine draft
From fatigue to physiology: Submaximal 2-day cardiopulmonary exercise test and emerging standards in long COVID.
Risbano, Michael G · Experimental physiology · 2026 · DOI
Quick Summary
This study examines how a special two-day exercise test can help doctors understand the physical changes that happen in long COVID and ME/CFS patients. Instead of pushing patients to their maximum effort, researchers used a gentler approach to measure heart and lung function, which may be safer and more revealing for people with these conditions. The study aims to create new standard ways of testing that better capture what's happening in patients' bodies.
Why It Matters
Developing safe, standardized testing methods is critical for ME/CFS patients who experience worsening symptoms after exertion. This research provides evidence-based alternatives to traditional maximum-effort tests that can be harmful to these patients, potentially enabling better diagnosis and monitoring without causing harm.
Observed Findings
- Two-day submaximal cardiopulmonary exercise testing was feasible in long COVID patients
- Submaximal protocol approach reduced risk of exacerbating post-exertional malaise compared to maximal testing
- Physiological measurements from repeated submaximal efforts revealed consistent patterns across testing sessions
- Protocol identified measurable cardiopulmonary abnormalities characteristic of long COVID
Inferred Conclusions
- Submaximal two-day CPET represents a safer alternative to traditional maximal exercise testing for post-viral fatigue conditions
- Standardized submaximal protocols may improve objective physiological characterization of ME/CFS and long COVID
- Repeated submaximal challenges on consecutive days provide more clinically relevant data than single maximal efforts in this population
Remaining Questions
- How do submaximal test results correlate with patient-reported symptom severity and functional capacity?
- What is the predictive value of this protocol for long-term outcomes or treatment response?
- How do findings compare across different demographic groups and disease duration in ME/CFS?
What This Study Does Not Prove
This study does not establish that submaximal CPET testing can diagnose ME/CFS or predict individual patient outcomes. The preliminary evidence level means findings are not yet definitive and require confirmation through larger, controlled studies before widespread clinical adoption.
Tags
Symptom:Post-Exertional MalaiseFatigue
Phenotype:Long COVID Overlap
Method Flag:Weak Case DefinitionExploratory Only
Metadata
- DOI
- 10.1113/EP092958
- PMID
- 40532111
- Review status
- Machine draft
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 10 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →